Bereich
Brustzentrum St.Gallen
BZ · Dept. IV
Cytokine interactions in human mixed lymphocyte culture.
Driessen S, Kirchner H, Rink L. Cytokine interactions in human mixed lymphocyte culture. Transplantation 1994; 57:1638-42.
15.06.1994Cytokine interactions in human mixed lymphocyte culture.
15.06.1994Transplantation 1994; 57:1638-42
Driessen Susanne, Kirchner H, Rink L
Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK)
Joss R, Bacchi M, Buser K, Kirchner V, Neuenschwander H, Orth B, Aapro M, Thürlimann B. Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol 1994; 5:253-8.
01.03.1994Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK)
01.03.1994Ann Oncol 1994; 5:253-8
Joss R A, Bacchi M, Buser K, Kirchner V, Neuenschwander H, Orth B, Aapro M S, Thürlimann Beat
Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study
Thürlimann B, Morant R, Jungi W, Radziwill A. Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study. Support Care Cancer 1994; 2:61-5.
01.01.1994Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study
01.01.1994Support Care Cancer 1994; 2:61-5
Thürlimann Beat, Morant R, Jungi W F, Radziwill A
Present status and potential role of high-dose adjuvant chemotherapy in breast cancer with poor prognosis
Thürlimann B. Present status and potential role of high-dose adjuvant chemotherapy in breast cancer with poor prognosis. Arch Gynecol Obstet 1994; 255 Suppl 2:S379-80.
01.01.1994Present status and potential role of high-dose adjuvant chemotherapy in breast cancer with poor prognosis
01.01.1994Arch Gynecol Obstet 1994; 255 Suppl 2:S379-80
Thürlimann Beat
Progress in the treatment and palliation of advanced breast cancer: does the dose of pamidronate determine its effects?
Thürlimann B. Progress in the treatment and palliation of advanced breast cancer: does the dose of pamidronate determine its effects?. Ann Oncol 1994; 5 Suppl 7:S45-7.
01.01.1994Progress in the treatment and palliation of advanced breast cancer: does the dose of pamidronate determine its effects?
01.01.1994Ann Oncol 1994; 5 Suppl 7:S45-7
Thürlimann Beat
Klinisch relevante Prognosefaktoren beim Mammakarzinom
Costa S, von Minkwitz G, Gremm B, Huober J, Fersis N, Schmid H, Wallwiener D, Müller H, Eppenberger U, Diel I, Kaufmann M, Bastert G. Klinisch relevante Prognosefaktoren beim Mammakarzinom. Klin Lab 1994; 40:1153-1166.
01.01.1994Klinisch relevante Prognosefaktoren beim Mammakarzinom
01.01.1994Klin Lab 1994; 40:1153-1166
Costa SD, von Minkwitz G, Gremm B, Huober Jens, Fersis N, Schmid H, Wallwiener D, Müller H, Eppenberger U, Diel IJ, Kaufmann M, Bastert G
Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial
Thürlimann B, Waldburger R, Senn H, Thiébaud D. Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial. Ann Oncol 1992; 3:619-23.
01.09.1992Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial
01.09.1992Ann Oncol 1992; 3:619-23
Thürlimann Beat, Waldburger R, Senn H J, Thiébaud D
Effective prevention of chemotherapy--induced phlebitis by low-dose heparin: a prospective randomised trial
Thürlimann B, Bachmann I. Effective prevention of chemotherapy--induced phlebitis by low-dose heparin: a prospective randomised trial. Ann Oncol 1992; 3:311-3.
01.04.1992Effective prevention of chemotherapy--induced phlebitis by low-dose heparin: a prospective randomised trial
01.04.1992Ann Oncol 1992; 3:311-3
Thürlimann Beat, Bachmann I
[Peripheral spontaneous remission of hairy cell leukemia following transfusion-associated hepatitis C]
Morant R, Thürlimann B, Jungi W, Schmid L, Holdener E, Schmid U, Senn H. [Peripheral spontaneous remission of hairy cell leukemia following transfusion-associated hepatitis C]. Schweiz Med Wochenschr 1991; 121:344-6.
09.03.1991[Peripheral spontaneous remission of hairy cell leukemia following transfusion-associated hepatitis C]
09.03.1991Schweiz Med Wochenschr 1991; 121:344-6
Morant R, Thürlimann Beat, Jungi W F, Schmid L, Holdener E, Schmid U, Senn H J
Metabolism of debrisoquine and susceptibility to breast cancer
Huober J, Bertram B, Petru E, Kaufmann M, Schmähl D. Metabolism of debrisoquine and susceptibility to breast cancer. Breast cancer research and treatment 1991; 18:43-8.
01.03.1991Metabolism of debrisoquine and susceptibility to breast cancer
01.03.1991Breast cancer research and treatment 1991; 18:43-8
Huober Jens, Bertram B, Petru E, Kaufmann M, Schmähl D
Recombinant human granulocyte-macrophage colony-stimulating factor for the intensification of cytostatic treatment in advanced cancer
Schmid L, Thürlimann B, Müller M, Senn H. Recombinant human granulocyte-macrophage colony-stimulating factor for the intensification of cytostatic treatment in advanced cancer. Recent Results Cancer Res 1991; 121:173-81.
01.01.1991Recombinant human granulocyte-macrophage colony-stimulating factor for the intensification of cytostatic treatment in advanced cancer
01.01.1991Recent Results Cancer Res 1991; 121:173-81
Schmid L, Thürlimann Beat, Müller M, Senn H J
Ceftriaxone and amikacin versus ceftazidime and amikacin in febrile granulocytopenia
Schmid L, Jeschko M, Wilder-Smith C, Schafroth U, Thürlimann B, Pedrazzini A, Senn H. Ceftriaxone and amikacin versus ceftazidime and amikacin in febrile granulocytopenia. Chemotherapy 1991; 37:346-52.
01.01.1991Ceftriaxone and amikacin versus ceftazidime and amikacin in febrile granulocytopenia
01.01.1991Chemotherapy 1991; 37:346-52
Schmid L, Jeschko M, Wilder-Smith C, Schafroth U, Thürlimann Beat, Pedrazzini A, Senn H
Anthracycline-carboplatin combination in metastatic breast cancer
Thürlimann B, Senn H, Jungi W. Anthracycline-carboplatin combination in metastatic breast cancer. J Cancer Res Clin Oncol 1990; 116:13-4.
01.01.1990Anthracycline-carboplatin combination in metastatic breast cancer
01.01.1990J Cancer Res Clin Oncol 1990; 116:13-4
Thürlimann Beat, Senn H J, Jungi W F
[Safety problems in the handling of cytostatics]
Thürlimann B, Senn H. [Safety problems in the handling of cytostatics]. Ther Umsch 1988; 45:403-7.
01.06.1988[Safety problems in the handling of cytostatics]
01.06.1988Ther Umsch 1988; 45:403-7
Thürlimann Beat, Senn H J
Aspergillus brain abscess. A case report
Coccia-Portugal M, Sieling W, Terblanche A, Thürlimann B, van Rensburg P, Greyling S, Stevens K, Heyneke P, Falkson G. Aspergillus brain abscess. A case report. S Afr Med J 1987; 71:116-8.
24.01.1987Aspergillus brain abscess. A case report
24.01.1987S Afr Med J 1987; 71:116-8
Coccia-Portugal M A, Sieling W L, Terblanche A P, Thürlimann Beat, van Rensburg P G, Greyling S A, Stevens K, Heyneke P J, Falkson G
Gonadotrophin-releasing hormone analogue agonists--a new approach in advanced prostatic cancer
Thürlimann B, Falkson G. Gonadotrophin-releasing hormone analogue agonists--a new approach in advanced prostatic cancer. S Afr Med J 1985; 68:888-9.
07.12.1985Gonadotrophin-releasing hormone analogue agonists--a new approach in advanced prostatic cancer
07.12.1985S Afr Med J 1985; 68:888-9
Thürlimann Beat, Falkson G
[Importance of thyroid hormone determination in the diagnosis of hyperthyroidism--significant improvement in medical assessment using decision theory results]
Hess C, Brodda K, v Schulthess G, Thürlimann B, Wurstbauer K. [Importance of thyroid hormone determination in the diagnosis of hyperthyroidism--significant improvement in medical assessment using decision theory results]. Nuklearmedizin 1985; 24:127-34.
01.06.1985[Importance of thyroid hormone determination in the diagnosis of hyperthyroidism--significant improvement in medical assessment using decision theory results]
01.06.1985Nuklearmedizin 1985; 24:127-34
Hess C F, Brodda K, v Schulthess G K, Thürlimann Beat, Wurstbauer K